MarketWatch
A California bill is “more focused on victim protections without any new investor protections,” according to analysts.
Bloomberg Markets
Eli Lilly & Co. plans to buy Merida Biosciences Inc. for as much as $2.88 billion in cash to expand in autoimmune and allergic diseases, part of an effort to build beyond the weight-loss and diabetes markets that made it the largest pharmaceutical company in the world.
Lilly has been on a record spending spree, having announced more than $20 billion in deals so far in 2026. The drugmaker has been using the windfall from its Zepbound and Mounjaro shots to diversify its pipeline, mainly targeting
Bloomberg Markets
The Mexican peso is finally drawing the attention of investors who have, for most of the year, overlooked the currency to chase higher returns elsewhere in emerging markets.
Bloomberg Markets
A key panel of the Swiss parliament backed a compromise proposal on UBS Group AG’s capital requirements that would allow them to meet 50% of the new amount with debt, handing an interim win to the Zurich-based bank.
MarketWatch
Top officials in the Trump administration have taken the wraps off a plan for tackling the federal government’s persistent deficits.
Yahoo Finance
Yahoo Finance